Innovation to Impact: GestVision

November 22, 2016

GestVision, founded by CEO Wendy Davis (Yale SOM) is developing a simple urine test to detect preeclampsia which impacts one in 12 pregnancies in the US and puts tens of thousands of pregnant women and their unborn children at risk of death or serious health complications.

“Innovation to Impact” is a video series highlighting leading Yale entrepreneurs who have turned their groundbreaking research and innovative ideas into businesses that have raised $1M or more and are poised to have significant positive impact on human lives. “At Yale we don’t just want to make new things, we want to make things better.” — Peter Salovey, Yale President